Xenova Group PLC (XNVA) Grants Licence To PharmaEngine, Inc.
10/19/2005 5:13:16 PM
More...
|
Xenova Group PLC (XNVA) -- Preliminary Results For The Year Ended 31 December 2004
10/19/2005 5:12:54 PM
More...
|
Xenova Group PLC (XNVA): Anti-Smoking Vaccine TA-NIC Preliminary 12 Month Clinical Trial Results
10/19/2005 5:12:54 PM
More...
|
Xenova Group PLC (XNVA): Preliminary Results For The Year Ended 31 December 2003
10/19/2005 5:12:51 PM
More...
|
Xenova Group PLC (XNVA) -- TransMID Obtains Orphan Drug Designation In Japan
10/19/2005 5:12:42 PM
More...
|
The Week In Review: Another Slide For Biotech
10/19/2005 5:12:20 PM
More...
|
Xenova Group PLC (XNVA) Licenses DISC-HSV And DISC-GM-CSF Vector Technologies To Oxxon Therapeutics Inc.; $83 Million; Stock Up
10/19/2005 5:12:16 PM
More...
|
Xenova Group PLC (XNVA) Program Update; Millennium Pharmaceuticals, Inc. (MLNM) Has Decided To Cease Funding The XR5944/XR11576 Program After Completion Of The On-Going Phase I Studies
10/19/2005 5:12:13 PM
More...
|
Xenova Group PLC (XNVA) Licenses TA-CIN To Cancer Research Technology
10/19/2005 5:12:07 PM
More...
|
Xenova Group PLC (XNVA) And FDA Reach Agreement On SPA Phase III Trial Programme For TransMID -- Enrollment To Begin Immediately
10/19/2005 5:11:15 PM
More...
|
|